XW0337CIntroduction of Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 12
- Billable / Specific Code
- New for FY 2027
XW0337C is a billable ICD-10-PCS procedure code for Introduction of Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 12. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRGs 008, 010, 019. The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. The Alphabetic Index lists this code under Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | W | Anatomical Regions |
| 3 | Operation | 0 | Introduction |
| 4 | BodyPart | 3 | Peripheral Vein |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | 7 | Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy |
| 7 | Qualifier | C | New Technology Group 12 |
In the ICD-10-PCS Alphabetic Index
The FY 2027 ICD-10-PCS Alphabetic Index refers to XW0337C as Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy. These index entries lead to this code:
To code zimislecel allogeneic stem Cell-Derived islet cell therapy, open the FY 2027 ICD-10-PCS Alphabetic Index at Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy. The entry lists XW0337C directly as a complete, billable code.
Code History
- 3E033U1 — Introduce Nonaut Pancr Islet in Periph Vein, Perc
Similar Procedure Codes
Questions About XW0337C
Is XW0337C a billable code?
Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 12 on inpatient claims from October 1, 2026 through September 30, 2027.
What is the ICD-10-PCS code for zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy?
The ICD-10-PCS Alphabetic Index lists Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy under code XW0337C, Introduction of Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 12, billable on inpatient claims in fiscal year 2027.
What do the characters in XW0337C mean?
The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 3 is the BodyPart (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character 7 is the Device/Substance/Technology (Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy); the 7th character C is the Qualifier (New Technology Group 12).
What MS-DRG does XW0337C group to?
On an inpatient stay, Introduction of Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 12 maps to MS-DRGs 008, 010, 019, with relative weights from 5.5122 to 7.5461. The MS-DRG sets the fixed Medicare payment for the stay.
